- Ideas
- Markets
- Cryptocurrencies
- Currencies
- Stocks
- Earnings Calendar
- Stock Screener
- Large-Cap
- Top gainers
- Top losers
- Most active
- Most volatile
- Overbought
- Oversold
- All time high
- All time low
- Sector & Industry
Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc
- Indices
S&P 500, Nasdaq Composite, Dow 30, Nikkei 225, DAX Index, FTSE 100
- Futures
- Bonds
US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y
- Scripts
- Editors' picks
- Oscillators
- Centered oscillators
- Volatility
- Trend analysis
- Volume
- Moving average
- Exponential Moving Average (EMA)
- Weighted Moving Average (WMA)
- Simple Moving Average (SMA)
- Hull Moving Average (HMA)
- Kaufman's Adaptive Moving Average (KAMA)
- Smoothed Moving Average (SMMA)
- Variable Index Dynamic Average (VIDYA)
- Volume-weighted Moving Average (VWMA)
- Fractal Adaptive Moving Average (FRAMA)
- Double Exponential Moving Average (DEMA)
- Breadth indicators
- Bill Williams indicators
- Screener
- Streams
- Brokers
- Chart
- More
UPDATE - Revive Therapeutics Announces U.S. FDA Approval of Confirmatory Phase 3 Clinical Trial for Bucillamine in COVID-19 www.globenewswire.com
REVIVE THERAPEUTICS has a Market Capitalization of only 27.158M, while the Net Income (FY) reveals a debt, -1.028M. Some analists predict an Average Target Price of 2.36 usd. The indicators are bullish on most timeframes. Still a lot of room to grow, with that huge volume. If you are interested to test some amazing buy and sell indicators, which give the signal...
News
Made with